Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 68, Issue suppl 2, Pages ii37-ii44
Publisher
Oxford University Press (OUP)
Online
2013-06-14
DOI
10.1093/jac/dkt143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tigecycline use in serious nosocomial infections: a drug use evaluation
- (2016) Matteo Bassetti et al. BMC INFECTIOUS DISEASES
- Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies
- (2013) M. Bassetti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies
- (2013) P. Montravers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies
- (2013) C. Eckmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapy of 1,025 Severely Ill Patients with Complicated Infections in a German Multicenter Study: Safety Profile and Efficacy of Tigecycline in Different Treatment Modalities
- (2012) Klaus-Friedrich Bodmann et al. CHEMOTHERAPY
- Effectiveness and Safety of Tigecycline: Focus on Use for Approved Indications
- (2012) K. Z. Vardakas et al. CLINICAL INFECTIOUS DISEASES
- Prospective, Non-Interventional, Multi-Centre Trial of Tigecycline in the Treatment of Severely Ill Patients with Complicated Infections – New Insights into Clinical Results and Treatment Practice
- (2011) Christian Eckmann et al. CHEMOTHERAPY
- Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009
- (2011) Michael J. Dowzicky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of tigecycline and comparators against Gram-negative pathogens isolated from blood in Europe (2004–2009)
- (2011) Arjana Tambic Andrasevic et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
- (2010) Yun Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tigecycline for severe infections: the gap between the warning and the necessity
- (2010) D. Curcio JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
- (2010) Joseph S. Solomkin et al. Surgical Infections
- Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
- (2009) Matthew Falagas et al. CURRENT DRUG METABOLISM
- Treatment of Complicated Skin and Soft Tissue Infections
- (2009) Addison K. May et al. Surgical Infections
- Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit
- (2008) S. Swoboda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Outcome of Necrotizing Skin and Soft Tissue Infections
- (2008) Oliver L. Gunter et al. Surgical Infections
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started